P1209: PERIPHERAL BLOOD CTDNA-SEQUENCING ENABLES PREDICTION OF OUTCOMES IN PATIENTS WITH PRIMARY CENTRAL NERVOUS SYSTEM LYMPHOMA USING A DYNAMIC RISK MODEL
Main Authors: | , , , , , , , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2023-08-01
|
Series: | HemaSphere |
Online Access: | http://journals.lww.com/10.1097/01.HS9.0000971732.45690.bd |
_version_ | 1797280161880604672 |
---|---|
author | Jan-Michel Heger Julia Mattlener Philipp Gödel Hyatt Balke-Want Noëlle Sieg Nadine Kutsch Richard Lewis Fabian Ullrich Roland F. Schwarz Kerstin Becker Jonathan Weiss H. Christian Reinhardt Michael Hallek Peter Borchmann Bastian von Tresckow Sven Borchmann |
author_facet | Jan-Michel Heger Julia Mattlener Philipp Gödel Hyatt Balke-Want Noëlle Sieg Nadine Kutsch Richard Lewis Fabian Ullrich Roland F. Schwarz Kerstin Becker Jonathan Weiss H. Christian Reinhardt Michael Hallek Peter Borchmann Bastian von Tresckow Sven Borchmann |
author_sort | Jan-Michel Heger |
collection | DOAJ |
first_indexed | 2024-03-07T16:36:14Z |
format | Article |
id | doaj.art-4da024e7441c4c5c9cdc01e980255a86 |
institution | Directory Open Access Journal |
issn | 2572-9241 |
language | English |
last_indexed | 2024-03-07T16:36:14Z |
publishDate | 2023-08-01 |
publisher | Wiley |
record_format | Article |
series | HemaSphere |
spelling | doaj.art-4da024e7441c4c5c9cdc01e980255a862024-03-03T09:43:15ZengWileyHemaSphere2572-92412023-08-017e45690bd10.1097/01.HS9.0000971732.45690.bd202308003-01107P1209: PERIPHERAL BLOOD CTDNA-SEQUENCING ENABLES PREDICTION OF OUTCOMES IN PATIENTS WITH PRIMARY CENTRAL NERVOUS SYSTEM LYMPHOMA USING A DYNAMIC RISK MODELJan-Michel Heger0Julia Mattlener1Philipp Gödel2Hyatt Balke-Want3Noëlle Sieg4Nadine Kutsch5Richard Lewis6Fabian Ullrich7Roland F. Schwarz8Kerstin Becker9Jonathan Weiss10H. Christian Reinhardt11Michael Hallek12Peter Borchmann13Bastian von Tresckow14Sven Borchmann151 Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf, University of Cologne, Medical Faculty and University Hospital Cologne, Cologne, Germany, Cologne, Germany1 Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf, University of Cologne, Medical Faculty and University Hospital Cologne, Cologne, Germany, Cologne, Germany1 Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf, University of Cologne, Medical Faculty and University Hospital Cologne, Cologne, Germany, Cologne, Germany1 Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf, University of Cologne, Medical Faculty and University Hospital Cologne, Cologne, Germany, Cologne, Germany1 Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf, University of Cologne, Medical Faculty and University Hospital Cologne, Cologne, Germany, Cologne, Germany1 Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf, University of Cologne, Medical Faculty and University Hospital Cologne, Cologne, Germany, Cologne, Germany1 Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf, University of Cologne, Medical Faculty and University Hospital Cologne, Cologne, Germany, Cologne, Germany4 Cancer Center Cologne Essen (CCCE), Essen, Germany2 Cancer Center Cologne Essen (CCCE), Cologne, Germany8 West German Genome Center (WGGC), University of Cologne, Cologne, Germany1 Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf, University of Cologne, Medical Faculty and University Hospital Cologne, Cologne, Germany, Cologne, Germany4 Cancer Center Cologne Essen (CCCE), Essen, Germany1 Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf, University of Cologne, Medical Faculty and University Hospital Cologne, Cologne, Germany, Cologne, Germany1 Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf, University of Cologne, Medical Faculty and University Hospital Cologne, Cologne, Germany, Cologne, Germany4 Cancer Center Cologne Essen (CCCE), Essen, Germany1 Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf, University of Cologne, Medical Faculty and University Hospital Cologne, Cologne, Germany, Cologne, Germanyhttp://journals.lww.com/10.1097/01.HS9.0000971732.45690.bd |
spellingShingle | Jan-Michel Heger Julia Mattlener Philipp Gödel Hyatt Balke-Want Noëlle Sieg Nadine Kutsch Richard Lewis Fabian Ullrich Roland F. Schwarz Kerstin Becker Jonathan Weiss H. Christian Reinhardt Michael Hallek Peter Borchmann Bastian von Tresckow Sven Borchmann P1209: PERIPHERAL BLOOD CTDNA-SEQUENCING ENABLES PREDICTION OF OUTCOMES IN PATIENTS WITH PRIMARY CENTRAL NERVOUS SYSTEM LYMPHOMA USING A DYNAMIC RISK MODEL HemaSphere |
title | P1209: PERIPHERAL BLOOD CTDNA-SEQUENCING ENABLES PREDICTION OF OUTCOMES IN PATIENTS WITH PRIMARY CENTRAL NERVOUS SYSTEM LYMPHOMA USING A DYNAMIC RISK MODEL |
title_full | P1209: PERIPHERAL BLOOD CTDNA-SEQUENCING ENABLES PREDICTION OF OUTCOMES IN PATIENTS WITH PRIMARY CENTRAL NERVOUS SYSTEM LYMPHOMA USING A DYNAMIC RISK MODEL |
title_fullStr | P1209: PERIPHERAL BLOOD CTDNA-SEQUENCING ENABLES PREDICTION OF OUTCOMES IN PATIENTS WITH PRIMARY CENTRAL NERVOUS SYSTEM LYMPHOMA USING A DYNAMIC RISK MODEL |
title_full_unstemmed | P1209: PERIPHERAL BLOOD CTDNA-SEQUENCING ENABLES PREDICTION OF OUTCOMES IN PATIENTS WITH PRIMARY CENTRAL NERVOUS SYSTEM LYMPHOMA USING A DYNAMIC RISK MODEL |
title_short | P1209: PERIPHERAL BLOOD CTDNA-SEQUENCING ENABLES PREDICTION OF OUTCOMES IN PATIENTS WITH PRIMARY CENTRAL NERVOUS SYSTEM LYMPHOMA USING A DYNAMIC RISK MODEL |
title_sort | p1209 peripheral blood ctdna sequencing enables prediction of outcomes in patients with primary central nervous system lymphoma using a dynamic risk model |
url | http://journals.lww.com/10.1097/01.HS9.0000971732.45690.bd |
work_keys_str_mv | AT janmichelheger p1209peripheralbloodctdnasequencingenablespredictionofoutcomesinpatientswithprimarycentralnervoussystemlymphomausingadynamicriskmodel AT juliamattlener p1209peripheralbloodctdnasequencingenablespredictionofoutcomesinpatientswithprimarycentralnervoussystemlymphomausingadynamicriskmodel AT philippgodel p1209peripheralbloodctdnasequencingenablespredictionofoutcomesinpatientswithprimarycentralnervoussystemlymphomausingadynamicriskmodel AT hyattbalkewant p1209peripheralbloodctdnasequencingenablespredictionofoutcomesinpatientswithprimarycentralnervoussystemlymphomausingadynamicriskmodel AT noellesieg p1209peripheralbloodctdnasequencingenablespredictionofoutcomesinpatientswithprimarycentralnervoussystemlymphomausingadynamicriskmodel AT nadinekutsch p1209peripheralbloodctdnasequencingenablespredictionofoutcomesinpatientswithprimarycentralnervoussystemlymphomausingadynamicriskmodel AT richardlewis p1209peripheralbloodctdnasequencingenablespredictionofoutcomesinpatientswithprimarycentralnervoussystemlymphomausingadynamicriskmodel AT fabianullrich p1209peripheralbloodctdnasequencingenablespredictionofoutcomesinpatientswithprimarycentralnervoussystemlymphomausingadynamicriskmodel AT rolandfschwarz p1209peripheralbloodctdnasequencingenablespredictionofoutcomesinpatientswithprimarycentralnervoussystemlymphomausingadynamicriskmodel AT kerstinbecker p1209peripheralbloodctdnasequencingenablespredictionofoutcomesinpatientswithprimarycentralnervoussystemlymphomausingadynamicriskmodel AT jonathanweiss p1209peripheralbloodctdnasequencingenablespredictionofoutcomesinpatientswithprimarycentralnervoussystemlymphomausingadynamicriskmodel AT hchristianreinhardt p1209peripheralbloodctdnasequencingenablespredictionofoutcomesinpatientswithprimarycentralnervoussystemlymphomausingadynamicriskmodel AT michaelhallek p1209peripheralbloodctdnasequencingenablespredictionofoutcomesinpatientswithprimarycentralnervoussystemlymphomausingadynamicriskmodel AT peterborchmann p1209peripheralbloodctdnasequencingenablespredictionofoutcomesinpatientswithprimarycentralnervoussystemlymphomausingadynamicriskmodel AT bastianvontresckow p1209peripheralbloodctdnasequencingenablespredictionofoutcomesinpatientswithprimarycentralnervoussystemlymphomausingadynamicriskmodel AT svenborchmann p1209peripheralbloodctdnasequencingenablespredictionofoutcomesinpatientswithprimarycentralnervoussystemlymphomausingadynamicriskmodel |